Rosenkranz, Alexander R.

Lipocalin-2 ameliorates granulocyte functionality

Schroll, A., Eller, K., Feistritzer, C., Nairz, M., Sonnweber, T., Moser, P. A., Rosenkranz, A. R., Theurl, I., & Weiss, G. (2012) · European Journal of Immunology

Chemokine receptors and signalingNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 135

Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation

Moschovaki Filippidou, F., Kirsch, A. H., Thelen, M., Kétszeri, M., Artinger, K., Aringer, I., Schabhüttl, C., Mooslechner, A. A., Frauscher, B., Pollheimer, M., et al. (2020) · The American Journal of Pathology

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 66

Lipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritis

Eller, K., Schroll, A., Banas, M., Kirsch, A. H., Huber, J. M., Nairz, M., Skvortsov, S., Weiss, G., Rosenkranz, A. R., & Theurl, I. (2013) · PLoS ONE

Renal Diseases and GlomerulopathiesAcute Kidney Injury Research

Cited by 46

Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients

Egli-Spichtig, D., Hamid, A. K., Arroyo, E. M. P., Ketteler, M., Wiecek, A., Rosenkranz, A. R., Pasch, A., Lorenz, H., Hellmann, B., Karus, M., et al. (2023) · Clinical Kidney Journal

Parathyroid Disorders and TreatmentsDialysis and Renal Disease Management

Cited by 9